Home › Alcohol Use Disorder (AUD) › NCT07171359
TMS to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD)
Transcranial Magnetic Stimulation (TMS) to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD)
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * 18+ years old * Enrolled in the Intensive Outpatient Program at Another Chance Drug \& Alcohol Rehab Center of Portland, Portland, OR. * Diagnosed with Opioid Use Disorder * Diagnosed with Alcohol Use Disorder Exclusion Criteria: * Children \<18 years old * Pregnant * Non-English speaking * Currently taking prescription benzodiazepines or anti-convulsive medications * In active alcohol or opioid withdrawal * History of seizure disorder diagnosis * History of Schizophrenia, Bipolar Disorder, Mania
About the study
The study aims to explore the potential of Transcranial Magnetic Stimulation (TMS), particularly Theta Burst Stimulation (TBS), as an adjunctive treatment to enhance recovery outcomes (consumption and craving; withdrawal symptoms; mental, physical, sleep, and cognitive health; engagement with therapy, etc.) in individuals with Opioid Use Disorder (OUD) and individuals with Alcohol Use Disorder (AUD). This project will be completed in partnership with Another Chance Rehab (Portland): Portland's top addiction treatment program offering evidence-based treatment programs for a range of substance use disorders. Another Chance Rehab will serve as the project site for this work.
What is being tested
- TMS Low-Dose (device)
- TMS High-Dose (device)
Sponsor: Washington State University · Participants: 60 · Started: Jun 1, 2027
Contact the study team
- Matthew E Layton, MD, PhD · Phone: 509-389-1108
- Poppy M Gardiner, PhD · Phone: 509-428-4236
Official record on ClinicalTrials.gov — NCT07171359
Locations in the U.S.
| Oregon | Another Chance Drug & Alcohol Rehab Center of Portland, Portland |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.